VOYA Investment Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$512K Buy
145,819
+117,060
+407% +$480K ﹤0.01% 1707
2025
Q4
$96.9K Sell
28,759
-608
-2% -$1.58K ﹤0.01% 2267
2025
Q3
$38.5K Sell
29,367
-16,708
-36% -$17.3K ﹤0.01% 2402
2025
Q2
$33K Buy
46,075
+6,104
+15% +$4.79K ﹤0.01% 2643
2025
Q1
$58.8K Sell
39,971
-3,419
-8% -$8.14K ﹤0.01% 2525
2024
Q4
$192K Sell
43,390
-4,375
-9% -$17.8K ﹤0.01% 2405
2024
Q3
$197K Sell
47,765
-32,749
-41% -$176K ﹤0.01% 2487
2024
Q2
$525K Sell
80,514
-25,393
-24% -$180K ﹤0.01% 1975
2024
Q1
$922K Sell
105,907
-10,150
-9% -$123K ﹤0.01% 1673
2023
Q4
$1.33M Buy
116,057
+726
+0.6% +$7.18K ﹤0.01% 1529
2023
Q3
$1.11M Buy
115,331
+216
+0.2% +$2.12K ﹤0.01% 1575
2023
Q2
$1.22M Buy
115,115
+2,739
+2% +$29.4K ﹤0.01% 1559
2023
Q1
$1.18M Sell
112,376
-485
-0.4% -$5.43K ﹤0.01% 1562
2022
Q4
$1.4M Buy
112,861
+151
+0.1% +$1.71K ﹤0.01% 1489
2022
Q3
$1.17M Buy
112,710
+61,143
+119% +$693K ﹤0.01% 1550
2022
Q2
$594K Sell
51,567
-5,561
-10% -$65.5K ﹤0.01% 1726
2022
Q1
$719K Buy
57,128
+1,224
+2% +$14K ﹤0.01% 1696
2021
Q4
$652K Sell
55,904
-2,119
-4% -$26K ﹤0.01% 1845
2021
Q3
$757K Sell
58,023
-2,323
-4% -$30K ﹤0.01% 1781
2021
Q2
$776K Sell
60,346
-11,315
-16% -$130K ﹤0.01% 1817
2021
Q1
$801K Buy
71,661
+2,264
+3% +$23.9K ﹤0.01% 1733
2020
Q4
$790K Buy
69,397
+15,016
+28% +$164K ﹤0.01% 1637
2020
Q3
$489K Hold
54,381
﹤0.01% 1688
2020
Q2
$561K Sell
54,381
-22,533
-29% -$231K ﹤0.01% 1596
2020
Q1
$776K Buy
76,914
+1,518
+2% +$17.8K ﹤0.01% 1351
2019
Q4
$1M Buy
75,396
+15,981
+27% +$176K ﹤0.01% 1453
2019
Q3
$510K Hold
59,415
﹤0.01% 1748
2019
Q2
$650K Sell
59,415
-9,851
-14% -$110K ﹤0.01% 1609
2019
Q1
$785K Hold
69,266
﹤0.01% 1501
2018
Q4
$601K Buy
69,266
+2,678
+4% +$30.7K ﹤0.01% 1602
2018
Q3
$1.03M Hold
66,588
﹤0.01% 1401
2018
Q2
$1.07M Sell
66,588
-4,462
-6% -$66K ﹤0.01% 1348
2018
Q1
$918K Sell
71,050
-2,110
-3% -$26.3K ﹤0.01% 1434
2017
Q4
$918K Sell
73,160
-2,171
-3% -$28.4K ﹤0.01% 1467
2017
Q3
$995K Hold
75,331
﹤0.01% 1434
2017
Q2
$1.19M Buy
75,331
+7,828
+12% +$114K ﹤0.01% 1276
2017
Q1
$964K Hold
67,503
﹤0.01% 1352
2016
Q4
$864K Hold
67,503
﹤0.01% 1415
2016
Q3
$898 Hold
67,503
﹤0.01% 1379
2016
Q2
$739K Hold
67,503
﹤0.01% 1453
2016
Q1
$618K Hold
67,503
﹤0.01% 1563
2015
Q4
$655K Hold
67,503
﹤0.01% 1532
2015
Q3
$589K Sell
67,503
-10,552
-14% -$98.5K ﹤0.01% 1608
2015
Q2
$788K Hold
78,055
﹤0.01% 1610
2015
Q1
$1.05M Hold
78,055
﹤0.01% 1417
2014
Q4
$1M Hold
78,055
﹤0.01% 1443
2014
Q3
$847K Hold
78,055
﹤0.01% 1544
2014
Q2
$1M Buy
78,055
+2,945
+4% +$32K ﹤0.01% 1481
2014
Q1
$775K Hold
75,110
﹤0.01% 1644
2013
Q4
$730K Buy
75,110
+8,972
+14% +$80.5K ﹤0.01% 1677
2013
Q3
$656K Hold
66,138
﹤0.01% 1700
2013
Q2
$551K Buy
+66,138
New +$802K ﹤0.01% 1752

Other funds holding IRWD

VOYA Investment Management's IRWD Position: Q1 2026 in Review

VOYA Investment Management increased its Ironwood Pharmaceuticals (IRWD) stake by 407% in Q1 2026, buying an estimated $480K and bringing the position to 145,819 shares worth $512K. The position accounts for ﹤0.01% of the portfolio, ranked #1707.

VOYA Investment Management first reported a position in IRWD in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.4M in Q4 2022. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • VOYA Investment Management held 145,819 shares of Ironwood Pharmaceuticals worth $512K as of Q1 2026.
  • VOYA Investment Management bought 117,060 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $480K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of VOYA Investment Management's portfolio in Q1 2026, its #1707 holding.
  • VOYA Investment Management first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • VOYA Investment Management's Ironwood Pharmaceuticals position peaked at $1.4M in Q4 2022.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.